Zollinger-ellison Syndrome
📧 Sign up to get email alerts when something new happens for Zollinger-ellison Syndrome.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-04-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for Lansoprazole from Teva Pharmaceuticals USA, Inc. The submission concerns a supplemental chan…
-
FDA approval · 2012-02-16FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole from Lannett Company, Inc., authorizing a generic omeprazole product.
-
FDA approval · 2012-02-14FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for omeprazole from Sandoz Inc, confirming an update to the approved generic product labeling. This …
-
FDA approval · 2012-02-09FDA Approved: OMEPRAZOLE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for a generic omeprazole product from Quallent Pharmaceuticals Health LLC under ANDA075576. This…
-
FDA approval · 2012-01-31FDA Approved: LANSOPRAZOLE — Supplemental Application (Dr.Reddy's Laboratories Ltd.)
FDA approved a supplemental application for Lansoprazole from Dr. Reddy's Laboratories Ltd.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for Pantoprazole Sodium by Torrent Pharmaceuticals Limited. The approval denotes changes under a sup…
-
FDA approval · 2012-01-17FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for Pantoprazole Sodium by Lannett Company, Inc., authorizing the continued market approval of a gen…
-
FDA approval · 2011-12-07FDA Approved: PROTONIX I.V. — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application to authorize the intravenous form of Protonix (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfiz…
-
FDA approval · 2011-10-31FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals (Pfizer).
-
FDA approval · 2011-10-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc. The action…
-
FDA approval · 2011-06-01FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for PREVACID SOLUTAB (lansoprazole) to add a Solutab formulation, submitted by Takeda Pharmaceut…
-
FDA label_change · 2011-05-20FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for PROTONIX DELAYED-RELEASE (pantoprazole sodium) from Wyeth/Pfizer to update the product labeling.
-
FDA approval · 2011-01-20FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Lannett Company, Inc.)
FDA approved Lannett Company's original Abbreviated New Drug Application for pantoprazole sodium, enabling a generic pantoprazole product. T…
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE — Original Application (NorthStar RxLLC)
FDA approved the original application for pantoprazole submitted by NorthStar RxLLC, launching a generic pantoprazole product.
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Pantoprazole sodium from Torrent Pharmaceuticals Limited under an original ANDA; a generic version of pantoprazole for conditio…
-
FDA approval · 2011-01-19FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the original ANDA for pantoprazole sodium, a generic proton pump inhibitor manufactured by Mylan Pharmaceuticals. This approval…
-
FDA approval · 2011-01-06FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved a supplemental application for famotidine submitted by Baxter Healthcare Corporation, resulting in a label change for the produ…
-
FDA approval · 2010-11-23FDA Approved: OMEPRAZOLE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for Omeprazole from Sandoz Inc, granting approval for this generic proton pump inhibitor under an AN…
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome [Phase 3]
Reports the completion of a Phase 3 trial evaluating esomeprazole for gastric acid hypersecretory states, including Zollinger-Ellison syndro…
-
FDA approval · 2010-11-17FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for the generic omeprazole from Lannett Company, Inc., authorizing continued marketing under the…
-
FDA approval · 2010-10-29FDA Approved: FAMOTIDINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for famotidine from Dr. Reddy's Laboratories Limited, authorizing a modification to an existing …
-
FDA approval · 2010-09-03FDA Approved: PROTONIX DELAYED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for Protonix Delayed-Release (pantoprazole sodium) from Wyeth Pharmaceuticals LLC (a Pfizer subs…
-
FDA approval · 2010-09-03FDA Approved: OMEPRAZOLE AND SODIUM BICARBONATE — Supplemental Application (Oceanside Pharmaceuticals)
The FDA approved Oceanside Pharmaceuticals' supplemental application for Omeprazole and Sodium Bicarbonate.
-
FDA approval · 2010-09-03FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) submitted by Covis Pharma US, Inc., representing a labeling amen…
-
FDA approval · 2010-01-31FDA Approved: RANITIDINE — Supplemental Application (Pharmaceutical Associates, Inc.)
The FDA approved a supplemental application for ranitidine filed by Pharmaceutical Associates, Inc., updating the drug's labeling. This acti…